Fusion Expression of Conotoxin MⅦA and GST and Its Analgesic Activity

CHEN Yong-dui,ZHAN Jin-biao

DOI: https://doi.org/10.3969/j.issn.1005-8982.2008.06.015

2008-01-01

Abstract:[Objective] To construct fusion expression plasmid pGEX-2T/ MⅦA,then transform it into E. coli BL21 for expression,and evaluate the analgesic effect of the fusion protein on mice. [Methods] E. coli-preferable codon was employed to design the artificial gene of w-conotoxin MⅦA according to the amino-acid sequence. The DNA sequence encoding w-conotoxin MⅦA was synthesized and subsequently cloned into the expression vector pGEX-2T. The fusion protein was expressed in E. coli BL21 and affinitively purified on a Glutathione-Sepharose 4B column. The analgesic activity of fusion protein in mice was determined by the classic hot-plat method. [Results] The fusion protein was obtained and the pain thresholds were markedly elevated when the fusion toxin was intracranially administered to mice. [Conclusions] The fusion protein produced by genetic engineering shows strong dose-dependent analgesic activity. The fusion toxin can be easily produced in E. coli for research and clinical application.